Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference
Company announcement – No. 11 / 2022 Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference…
Company announcement – No. 11 / 2022 Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference…
JUPITER, Fla., April 04, 2022 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
Premal Patel, M.D., Ph.D., chief medical officer, has resigned to pursue a new career opportunity…
— Following Prespecified Review of Phase 1 Safety and Tolerability Data, Independent Data Monitoring Committee…
SCOTTSDALE, Ariz., April 04, 2022 (GLOBE NEWSWIRE) — Journey Medical Corporation (“Journey Medical”) (NADSAQ: DERM),…
Discussions ongoing with FDA through special protocol assessment (SPA) seeking agreement on planned pivotal Phase…
BERKELEY HEIGHTS, N.J., April 04, 2022 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
WALTHAM, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a…
BOSTON, April 04, 2022 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the…
CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical…
LONDON, April 04, 2022 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health…
WATERTOWN, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
• Co-founder and Chief Scientist Parag Mallick, Ph.D., to present lecture at Annual Congress of…
DURHAM, N.C., April 04, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology…
WORCESTER, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
LAS VEGAS, NV, April 04, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Digipath, Inc. (OTCQB:…
– Webcast will feature Professor Charles Swanton, TRACERx Chief Investigator and Achilles co-founder – –…
ALG-097558 demonstrates nanomolar potent antiviral activity and is up to 20-fold more active than nirmatrelvir…
NEWARK, Calif., April 04, 2022 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical…
Guidelines issued jointly by the American Heart Association, American College of Cardiology and Heart Failure Society…